BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search
 Company Profile
..
 

EpiVax, Inc. 

146 Clifford Street

Providence  Rhode Island  02903  U.S.A.
Phone: 401-272-2123 Fax: 401-272-7562


SEARCH JOBS


Industry
Biotechnology






 Company News
BioAtla Combines EpiVax, Inc.'s Immunogenicity Screening Into Their Express Humanization™ Platform 4/24/2013 11:14:03 AM    More...
EpiVax, Inc.-Novozymes Biopharma Tregitope-Albumin Fusion Moves "Paradigm-Shifting" Treatment for Diabetes Closer to Clinical Trials 2/12/2013 9:23:05 AM    More...
Funding for Orphan Disease Indication Will Compare EpiVax, Inc.'s Tregitope with IVIG 11/19/2012 10:08:25 AM    More...
EpiVax, Inc. Research on Tregitopes Wins 2010 AAPS Innovation in Biotechnology Award 5/25/2010 3:20:19 PM    More...
EpiVax, Inc. Tregitope Technology: a Paradigm Shift 3/3/2010 1:02:25 PM    More...
EpiVax, Inc. Receives National Institutes of Health (NIH) Grant for $390,000 to Optimize HIV Vaccine Delivery 12/1/2008 9:20:24 AM    More...
EpiVax, Inc. Receives $600,000 Grant to Develop Treatment for Diabetes from National Institutes of Health (NIH) 7/8/2008 8:42:53 AM    More...
Rhode Island Biotech EpiVax, Inc. Receives $500K Federal Grant to Reengineer FVIII using ''Immunoinformatics'' 6/27/2007 12:52:20 PM    More...
Rhode Island Biotechnology Company EpiVax, Inc. Receives $ 368K Federal Grant to Reengineer Botulinum Toxin Using ''Immunoinformatics'' 2/28/2007 12:13:32 PM    More...
Rhode Island Biotechnology Company EpiVax, Inc. Develops Tularemia Vaccine 1/31/2007 11:57:25 AM    More...
12

//-->